Login to Your Account

Financings Roundup

MethylGene Pulls in $35M for Cancer, Antifungal Candidates

By Jennifer Boggs

Friday, March 25, 2011
Coming out of a 2010 reorganization, Canadian firm MethylGene Inc. entered 2011 with a new CEO at the helm and late Thursday disclosed a C$34.5 million (US$35.3 million) financing round to boost work on its programs in cancer and fungal infections.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription